Literature DB >> 7909081

DRD2 Ser311/Cys311 polymorphism in schizophrenia.

S Shaikh, D Collier, M Arranz, D Ball, M Gill, R Kerwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7909081

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

2.  A search for association between schizophrenia and dopamine-related alleles.

Authors:  E Jönsson; S Brené; T Geijer; L Terenius; A Tylec; M L Persson; G Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 3.  Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models.

Authors:  M Kvajo; H McKellar; J A Gogos
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

4.  Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.

Authors:  Ina Giegling; Beatrice Balzarro; Stefano Porcelli; Martin Schäfer; Annette M Hartmann; Marion Friedl; Bettina Konte; Philipp Krämer; Hans-Jürgen Möller; Diana De Ronchi; Hans H Stassen; Alessandro Serretti; Dan Rujescu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08-15       Impact factor: 5.270

Review 5.  Genetic predictors of therapeutic response to clozapine: current status of research.

Authors:  Dalu Mancama; Maria J Arranz; Robert W Kerwin
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 6.  Molecular genetics of schizophrenia: past, present and future.

Authors:  Suman Prasad; Prachi Semwal; Smita Deshpande; Triptish Bhatia; V L Nimgaonkar; B K Thelma
Journal:  J Biosci       Date:  2002-02       Impact factor: 1.826

7.  The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.

Authors:  Stephen J Glatt; Erik G Jönsson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

8.  Genome-wide association study of treatment refractory schizophrenia in Han Chinese.

Authors:  Ying-Jay Liou; Hui-Hung Wang; Ming-Ta Michael Lee; Sheng-Chang Wang; Hung-Lun Chiang; Cheng-Chung Chen; Ching-Hua Lin; Ming-Shun Chung; Chien-Cheng Kuo; Ding-Lieh Liao; Ching-Kuan Wu; Chih-Min Liu; Yu-Li Liu; Hai-Gwo Hwu; I-Ching Lai; Shih-Jen Tsai; Chia-Hsiang Chen; Hui-Fen Liu; Yi-Chun Chou; Chien-Hsiun Chen; Yuan-Tsong Chen; Chen-Jee Hong; Jer-Yuarn Wu
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

9.  Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis.

Authors:  Hairong He; Huanhuan Wu; Lihong Yang; Fan Gao; Yajuan Fan; Junqin Feng; Xiancang Ma
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-09       Impact factor: 2.570

10.  Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population.

Authors:  Neetha N Vijayan; Sujatha Bhaskaran; Linda V Koshy; Chandrasekhar Natarajan; Lekshmy Srinivas; Chandrasekharan M Nair; Priya M Allencherry; Moinak Banerjee
Journal:  Behav Brain Funct       Date:  2007-07-25       Impact factor: 3.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.